Zimbabwe has cleared the use of Lenacapavir, a long-acting injectable medicine for HIV pre-exposure prophylaxis (PrEP), marking a major advancement in the country's HIV prevention efforts. The Medicines Control Authority of Zimbabwe (MCAZ)…
Published: 24 Nov 2025 at 05:34hrs | | by Staff reporter